Inequalities in healthcare disruptions during the COVID-19 pandemic: evidence from 12 UK population-based longitudinal studies.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
13 10 2022
Historique:
entrez: 13 10 2022
pubmed: 14 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

We investigated associations between multiple sociodemographic characteristics (sex, age, occupational social class, education and ethnicity) and self-reported healthcare disruptions during the early stages of the COVID-19 pandemic. Coordinated analysis of prospective population surveys. Community-dwelling participants in the UK between April 2020 and January 2021. Over 68 000 participants from 12 longitudinal studies. Self-reported healthcare disruption to medication access, procedures and appointments. Prevalence of healthcare disruption varied substantially across studies: between 6% and 32% reported any disruption, with 1%-10% experiencing disruptions in medication, 1%-17% experiencing disruption in procedures and 4%-28% experiencing disruption in clinical appointments. Females (OR 1.27; 95% CI 1.15 to 1.40; I Healthcare disruptions during the COVID-19 pandemic could contribute to the maintenance or widening of existing health inequalities.

Identifiants

pubmed: 36229151
pii: bmjopen-2022-064981
doi: 10.1136/bmjopen-2022-064981
pmc: PMC9561494
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e064981

Subventions

Organisme : Chief Scientist Office
ID : SCAF/15/02
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_20059
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00019/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N024397/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CS/16/4/32482
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG017644
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_20030
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00022/2
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: SVK is a member of the Scientific Advisory Group on Emergencies subgroup on ethnicity and COVID-19 and is cochair of the Scottish Government’s Ethnicity Reference Group on COVID-19. NC serves on a data safety monitoring board for trials sponsored by AstraZeneca.

Références

Twin Res Hum Genet. 2019 Dec;22(6):523-529
pubmed: 31526404
Health Econ. 2021 Jul;30(7):1711-1716
pubmed: 33890334
Int J Epidemiol. 2013 Dec;42(6):1640-8
pubmed: 23143611
Am J Emerg Med. 2020 Sep;38(9):1732-1736
pubmed: 32738468
Int J Epidemiol. 2013 Jun;42(3):689-700
pubmed: 22786799
Prog Pediatr Cardiol. 2020 Dec;59:101254
pubmed: 32837144
J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135
pubmed: 32324855
Comput Human Behav. 2020 Oct;111:106424
pubmed: 32398890
Br J Cancer. 2020 Oct;123(9):1351-1352
pubmed: 32814836
Int J Epidemiol. 2022 Jul 18;:
pubmed: 35849349
BMJ Open. 2021 Mar 18;11(3):e045813
pubmed: 33737441
Arthritis Care Res (Hoboken). 2021 Aug;73(8):1162-1170
pubmed: 33278068
Mov Disord. 2020 Dec;35(12):2129-2133
pubmed: 32860226
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
Scand J Gastroenterol. 2020 Jul;55(7):870-876
pubmed: 32615891
Int J Epidemiol. 2006 Feb;35(1):34-41
pubmed: 16155052
Lancet. 1971 Feb 27;1(7696):405-12
pubmed: 4100731
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Annu Rev Public Health. 2012 Apr;33:7-40
pubmed: 22224876
BMC Public Health. 2016 Aug 04;15:711
pubmed: 27488369
BMJ Qual Saf. 2022 Aug;31(8):561-564
pubmed: 35042766
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
BMJ Qual Saf. 2022 Aug;31(8):590-598
pubmed: 34824162
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
J Med Internet Res. 2020 Jun 2;22(6):e19361
pubmed: 32452816
Lancet Public Health. 2018 May;3(5):e226-e236
pubmed: 29685729
Ann Work Expo Health. 2019 Oct 11;63(8):930-936
pubmed: 31504129
PLoS One. 2021 Mar 4;16(3):e0247959
pubmed: 33662014
Risk Manag Healthc Policy. 2019 Feb 14;12:23-30
pubmed: 30858741
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Int J Epidemiol. 2013 Aug;42(4):978-91
pubmed: 23064411
Int J Epidemiol. 2006 Feb;35(1):49-54
pubmed: 16204333
Soc Sci Med. 2020 Dec;267:113146
pubmed: 32665063

Auteurs

Jane Maddock (J)

MRC Unit for Lifelong Health and Ageing, UCL, London, UK jane.maddock@ucl.ac.uk.

Sam Parsons (S)

Centre for Longitudinal Studies, Social Research Institute, UCL, London, UK.

Giorgio Di Gessa (G)

Department of Epidemiology and Public Health, UCL, London, UK.

Michael J Green (MJ)

MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK.

Ellen J Thompson (EJ)

Department of Twin Research and Genetic Epidemiology, School of Life Course & Population Sciences, King's College London, London, UK.

Anna J Stevenson (AJ)

Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.

Alex Sf Kwong (AS)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.
MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Eoin McElroy (E)

Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.

Gillian Santorelli (G)

Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Richard J Silverwood (RJ)

Centre for Longitudinal Studies, Social Research Institute, UCL, London, UK.

Gabriella Captur (G)

MRC Unit for Lifelong Health and Ageing, UCL, London, UK.

Nishi Chaturvedi (N)

MRC Unit for Lifelong Health and Ageing, UCL, London, UK.

Claire J Steves (CJ)

Department of Twin Research and Genetic Epidemiology, School of Life Course & Population Sciences, King's College London, London, UK.

Andrew Steptoe (A)

Department of Epidemiology and Public Health, UCL, London, UK.

Praveetha Patalay (P)

MRC Unit for Lifelong Health and Ageing, UCL, London, UK.
Centre for Longitudinal Studies, Social Research Institute, UCL, London, UK.

George B Ploubidis (GB)

Centre for Longitudinal Studies, Social Research Institute, UCL, London, UK.

Srinivasa Vittal Katikireddi (SV)

MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH